Centre Hospitalier Regional de Rimouski

Rimouski, Quebec G5L 5T1

1 studies enrolling now · 8 studies all time

What they study most

Chronic Lymphocytic Leukemia, Colorectal Cancer, Diffuse Large B-cell Lymphoma, KRAS G12C Lung Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Non-Small Cell Lung Cancer, Ovarian Cancer, Sarcoma

Studies at this site

• A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer — Recruiting now
• TAK-659 in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) — Stopped early
• Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma — Completed
• Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma — Completed
• Efficacy and Safety of Idelalisib in Combination With Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia — Stopped early
• Genetic Study in Patients With Stage II or Stage III Colon Cancer — Completed
• Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy — Completed
• Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer — Status unconfirmed